(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide a.k.a. SR18662 is a KLF5 inhibitor based on the optimized structure of ML264. It inhibits the growth of colorectal cancer in vitro and in vivo.

Catalog Number | T9307 |
Research Area | Others |
Molecular Formula | C16H19Cl2N3O4S |
CAS# | 2505001-62-5 |
Purity | 98.16% |
SMILES | CS(N(CC1)CCN1C(CNC(/C=C/c(cc1)cc(Cl)c1Cl)=O)=O)(=O)=O |
Size | 500 mg |
Supplier Page | https://www.targetmol.com/compound/2505001-62-5 |
Additional Information | https://www.targetmol.com/datasheet/T9307 |